Details for New Drug Application (NDA): 012967
✉ Email this page to a colleague
The generic ingredient in ORAGRAFIN SODIUM is ipodate sodium. There is one drug master file entry for this compound. Additional details are available on the ipodate sodium profile page.
Summary for 012967
Tradename: | ORAGRAFIN SODIUM |
Applicant: | Bracco |
Ingredient: | ipodate sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription